ONGLYZA is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Cardinal Health 107, Llc. The primary component is Saxagliptin Hydrochloride.
| Product ID | 55154-6931_048ab1ca-6e74-49ad-9a9e-c866a2b9ce01 |
| NDC | 55154-6931 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ONGLYZA |
| Generic Name | Saxagliptin |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2014-11-20 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022350 |
| Labeler Name | Cardinal Health 107, LLC |
| Substance Name | SAXAGLIPTIN HYDROCHLORIDE |
| Active Ingredient Strength | 5 mg/1 |
| Pharm Classes | Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2014-11-20 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA022350 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2014-11-20 |
| Marketing Category | NDA |
| Application Number | NDA022350 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2014-11-20 |
| Marketing End Date | 2018-02-28 |
| Ingredient | Strength |
|---|---|
| SAXAGLIPTIN HYDROCHLORIDE | 5 mg/1 |
| SPL SET ID: | e4f2a84f-5117-4738-b769-aba8debbddb0 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0310-6100 | ONGLYZA | SAXAGLIPTIN |
| 0310-6105 | ONGLYZA | SAXAGLIPTIN |
| 55154-6931 | ONGLYZA | SAXAGLIPTIN |